Sean O'Leary | Chair, Committee on Infectious Diseases, AAP; Professor, Pediatrics-Infectious Diseases
University Of Colorado Anschutz Medical Campus

Sean O'Leary, Chair, Committee on Infectious Diseases, AAP; Professor, Pediatrics-Infectious Diseases, University Of Colorado Anschutz Medical Campus

Sean O’Leary, MD, MPH is a Professor of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado, a pediatric infectious diseases specialist, an investigator at ACCORDS (Adult and Child Center for Outcomes Research and Delivery Science), and the Director of the Colorado Children’s Outcomes Network (COCONet), Colorado’s pediatric practice-based research network. With over 240 peer-reviewed publications, Dr. O’Leary’s primary area of research focuses on prevention of vaccine-preventable diseases through understanding clinical, attitudinal and infrastructural barriers to vaccination, and developing and testing interventions to address those barriers. Much of his recent work focuses on studying how best to communicate about vaccines in clinical settings. Dr. O’Leary is a member of the American Academy of Pediatrics (AAP) Council on School Health and serves as the Chair of the Committee on Infectious Diseases (the Red Book Committee) for the AAP. Dr. O’Leary served for many years as a liaison to the CDC’s Advisory Committee on Immunization Practices (ACIP) for the AAP and Pediatric Infectious Diseases Society, and until recent events served on several ACIP Work Groups, including COVID-19, RSV and HPV. He also serves as the co-chair of the Policy Committee for Immunize Colorado, as a Director for the National Foundation for Infectious Diseases, and as a member of the Steering Committee for Voices for Vaccines. Prior to his infectious diseases fellowship, Dr. O’Leary was a partner in a large general pediatric practice in Fort Collins, Colorado for 8 years.

Appearances:



Day 2 - Wednesday 1st April @ 12:25

Understanding the Growing Divide Between Childhood and Adult Vaccination

    li>
  •     Pediatric vaccination is more vulnerable than adult vaccination in the current climate.
  •     Panel will examine parental choices, provider trust, and policy support.
  •     Adult vaccination benefits from mandates, pharmacy access, and clinical backing.
  •     How are federal policies affecting the Vaccines for Children Program?
  •     What would state Medicaid programs need to do to replace the VFC program?
  •     How would those changes affect health equity?
  •     Goal: identify cross-cutting strategies to strengthen vaccination across all ages. 

Day 2 - Wednesday 1st April @ 17:10

Panel: Prove it's safe: Is this the new vaccine policy "norm?"

    th the traditional vaccine policy infrastructure in flux—most notably emerging guidance from FDA, disruption of long-standing ACIP processes, and threats to the vaccine injury compensation system— this panel will discuss these changes and their implications for vaccine access, healthy vaccine markets, and innovation.  How do we best respond to these changes and how do we most effectively communicate to a confused public?

     Topic to discuss include:
  •     Strategies for maintaining scientific integrity and public confidence in a fragmented system.
  •     The importance of medical societies in developing evidence-based vaccine recommendations.
  •     The role of new organizations (EVAT: Expert Vaccine Analysis Team and VIP: Vaccine Integrity Project)  as independent sources of vaccine science
  •     An assessment of the health of vaccine markets and the future of innovation
  •     Emerging legal threats for providers and manufacturers 

last published: 11/Mar/26 19:15 GMT

back to speakers